Get the latest news, insights, and market updates on LH (Labcorp Holdings Inc.). Explore the news page 4 on MyTopStock.com for investor discussions, analysis, and real-time stock performance coverage.
Death Clock Launches "Life Lab": An AI Health Concierge Democratizing Private-Doctor Level Care for the Mass Market
Death Clock, the world's #1 longevity app, today announced the launch of Life Lab, an advanced AI health concierge designed to shift healthcare from reactive treatment to proactive prevention. This major evolution brings "Medicine 3.0" capabilities to the public, including integrated blood work from over 4,800 Labcorp, Quest, and BioReference locations and the ability for users to upload existing records from their own physicians. All blood tests also include the biomarkers necessary to calculat Feb 2, 2026 - $LH
2 Unprofitable Stocks with Promising Prospects and 1 We Turn Down
Unprofitable companies can burn through cash quickly, leaving investors exposed if they fail to turn things around. Without a clear path to profitability, these businesses risk running out of capital or relying on dilutive fundraising. Jan 19, 2026 - $LH
Is Labcorp (LH) Quietly Reframing Its Oncology Innovation Story With Dividends And MRD Expansion?
Earlier this week, Labcorp Holdings Inc. declared a quarterly cash dividend of US$0.72 per share, payable on March 12, 2026 to shareholders of record as of February 27, 2026. In parallel, Labcorp expanded its Plasma Detect molecular residual disease portfolio with highly sensitive ctDNA tests for breast, lung and colon cancers, reinforcing its role in precision oncology diagnostics and personalized post-treatment monitoring. We’ll now examine how Labcorp’s expanded MRD testing portfolio... Jan 16, 2026 - $LH
Labcorp to Announce Fourth Quarter Financial Results on February 17, 2026
Labcorp Holdings Inc. (NYSE: LH), a global leader of innovative and comprehensive laboratory services, will release its financial results for the fourth quarter of 2025 before the market opens on Tuesday, February 17, 2026. The company will host a conference call and webcast beginning at 9 a.m. ET that day to discuss the results. The earnings press release and accompanying financial information will be posted on the Labcorp Investor Relations website. Jan 15, 2026 - $LH
Labcorp Declares Quarterly Dividend
Labcorp Holdings Inc. (NYSE: LH), a global leader of innovative and comprehensive laboratory services, announced today that its Board of Directors has declared a cash dividend of $0.72 per share of common stock. The dividend will be payable on March 12, 2026, to stockholders of record as of the close of business on February 27, 2026. Jan 14, 2026 - $LH
3 Value Stocks Walking a Fine Line
The low valuation multiples for value stocks provide a margin of safety that growth stocks rarely offer. However, the challenge lies in determining whether these cheap assets are genuinely undervalued or simply on sale due to their potentially deteriorating business models. Jan 14, 2026 - $LH
Labcorp Expands MRD Testing for Breast, Lung and Colon Cancer Recurrence Risk
Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, today announced the continued expansion of its molecular residual disease (MRD)i portfolio designed to help clinicians detect cancer recurrence earlier than traditional imaging. The expanded offerings include Labcorp Plasma Detect ID, a whole exome sequence-guided, personalized panel for patients with stage I–III breast cancer or stage I–IIIA non-small cell lung cancer, and the nationwide availability of Lab Jan 13, 2026 - $LH
Best Testosterone Replacement Therapy (TRT) 2026: Taurus Meds Consumer Analysis Examines Online TRT Access and At-Home Testosterone Treatment Options
Consumer Report Details Low Testosterone Treatment Costs, LabCorp and Quest Lab Testing, Licensed Provider Access, and What Men Need to Know Before Starting Online TRTWILMINGTON, DE, Jan. 12, 2026 (GLOBE NEWSWIRE) -- Disclaimer: This article is for informational purposes only. It is not medical advice. Testosterone replacement therapy requires evaluation by a licensed healthcare provider. If you access services through links in this article, a commission may be earned at no additional cost to yo Jan 13, 2026 - $LH
We use cookies and similar technologies to collect and process data such as browsing activity or unique identifiers.
Selecting "Allow All" to help us understand site usage and improve the platform.
Choosing "Essential Cookies Only" enables only the cookies necessary for core site functions, such as staying logged in.
For more information, please see our Privacy Policy.
Continue with Google
Continue with Facebook
Continue with Microsoft
Continue with Apple